Source disclosure: February 13, 2026
HABA LABORATORIES,INC. [4925.T]
TOKYO, Feb 19 (Pulse News Wire) – Haba Laboratories,Inc. (4925.T) reported consolidated results for Q3 FY2026 (ending March 2026).
72 billion (+1.3% YoY). 4%). net profit attributable to shareholders was ¥318 million (+44.2%).
2 billion with an equity ratio of 74.3%. For the next fiscal year, the company forecasts 6 billion (+4.0%).
Note: Financial figures from the earnings presentation have been removed pending correction. For accurate figures, refer to the company's earnings summary (kessan tanshin) filed separately on TDNet.
AI-translated content. 🟢 Confidence: High See terms •Financial results — FY2026/3 (consolidated)
| Metric | Current | YoY |
|---|---|---|
| Revenue | ¥8,719M | +1.3% |
| Operating profit | ¥513M | +132.4% |
| Net profit | ¥318M | +44.2% |
Next period forecast
Revenue
¥12,550M
+4.0%Op. profit
¥500M
-15.2%Net profit
¥480M
-16.7%Source: TDNet filing · Figures in millions of yen